Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition

Oncogene

Volumn 32, Issue 2, 2013, Pages 141-150

  Gupta, S K ^a   Oommen, S ^a   Aubry, M C ^a   Williams, B P ^a   Vlahakis, N E ^a  

^a MAYO CLINIC   (United States)

Author keywords

9 1 integrin; cell migration; EMT; lung cancer; metastasis

Indexed keywords

ALPHA9BETA1 INTEGRIN; ANTINEOPLASTIC AGENT; BETA CATENIN; INTEGRIN; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH;

ANIMALS; BETA CATENIN; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INTEGRINS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE;

MUS;

EID: 84872196637     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.41     Document Type: Article

References (38)

1. Radisky DC. Epithelial-mesenchymal transition. J Cell Sci 2005; 118: 4325-4326.
2. Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2006; 1796: 75-90.
3. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009; 119: 213-224.
4. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007; 39: 305-318. (Pubitemid 46897605)
5. Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 2009; 69: 7135-7139.
6. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-89.
7. Jung H, Lee KP, Park SJ, Park JH, Jang YS, Choi SY et al. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene 2008; 27: 2635-2647. (Pubitemid 351550879)
8. Hynes RO. Integrins: Bidirectional, allosteric signaling machines. Cell 2002; 110: 673-687. (Pubitemid 35283958)
9. Takada Y, Ye X, Simon S. The integrins. Genome Biol 2007; 8: 215.
10. Desgrosellier JS, Cheresh DA. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10: 9-22.
11. Singh P, Chen C, Pal-Ghosh S, Stepp MA, Sheppard D, Van De Water L. Loss of integrin alpha9beta1 results in defects in proliferation, causing poor reepithelialization during cutaneous wound healing. J Invest Dermatol 2009; 129: 217-228.
12. Rathinam R, Alahari SK. Important role of integrins in the cancer biology. Cancer Metastasis Rev 2010; 29: 223-237.
13. Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 2005; 115: 339-347. (Pubitemid 40385475)
14. Kim Y, Kugler MC, Wei Y, Kim KK, Li X, Brumwell AN et al. Integrin alpha3beta1-dependent beta-catenin phosphorylation links epithelial Smad signaling to cell contacts. J Cell Biol 2009; 184: 309-322.
15. Maschler S, Wirl G, Spring H, Bredow DV, Sordat I, Beug H et al. Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene 2005; 24: 2032-2041. (Pubitemid 40516196)
16. Chattopadhyay N, Wang Z, Ashman LK, Brady-Kalnay SM, Kreidberg JA. alpha3beta1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPmu expression and cell-cell adhesion. J Cell Biol 2003; 163: 1351-1362. (Pubitemid 38032095)
17. Timoshenko AV, Rastogi S, Lala PK. Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells. Br J Cancer 2007; 97: 1090-1098. (Pubitemid 47587011)
18. Brown MC, Staniszewska I, Lazarovici P, Tuszynski GP, Del Valle L, Marcinkiewicz C. Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. Neuro Oncol 2008; 10: 968-980.
19. Lydolph MC, Morgan-Fisher M, Hoye AM, Couchman JR, Wewer UM, Yoneda A. Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage. Exp Cell Res 2009; 315: 3312-3324.
20. Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese Jr RV et al. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol 2000; 20: 5208-5215. (Pubitemid 30431573)
21. Kajiya K, Hirakawa S, Ma B, Drinnenberg I, Detmar M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 2005; 24: 2885-2895. (Pubitemid 43079892)
22. Vlahakis NE, Young BA, Atakilit A, Sheppard D. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J Biol Chem 2005; 280: 4544-4552. (Pubitemid 40288622)
23. Bazigou E, Xie S, Chen C, Weston A, Miura N, Sorokin L et al. Integrin-Alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 2009; 17: 175-186.
24. Vlahakis NE, Young BA, Atakilit A, Hawkridge AE, Issaka RB, Boudreau N et al. Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem 2007; 282: 15187-15196. (Pubitemid 47093385)
25. Oommen S, Gupta SK, Vlahakis NE. Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: Identification of a specific {alpha}9{beta}1 binding site. J Biol Chem 2011; 286: 1083-1092.
26. Wheeler DL, Iida M, Dunn EF. The role of Src in solid tumors. Oncologist 2009; 14: 667-678.
27. Aleshin A, Finn RS. SRC: A century of science brought to the clinic. Neoplasia 2010; 12: 599-607.
28. Gupta SK, Vlahakis NE. Integrin alpha9beta1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase. J Cell Sci 2009; 122: 2043-2054.
29. Nam JS, Ino Y, Sakamoto M, Hirohashi S. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clin Cancer Res 2002; 8: 2430-2436. (Pubitemid 34753619)
30. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20: 781-810. (Pubitemid 39488658)
31. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signaling: Disease and therapies. Nat Rev Genet 2004; 5: 691-701. (Pubitemid 39150127)
32. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nature Cell Biology 2001; 3: 683-686. (Pubitemid 32624426)
33. Borok Z. Role for alpha3 integrin in EMT and pulmonary fibrosis. J Clin Invest 2009; 119: 7-10.
34. Alphonso A, Alahari SK. Stromal cells and integrins: Conforming to the needs of the tumor microenvironment. Neoplasia 2009; 11: 1264-1271.
35. Kim S, Kang HY, Nam EH, Choi MS, Zhao XF, Hong CS et al. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. Carcinogenesis 2010; 31: 597-606.
36. Song L, Morris M, Bagui T, Lee FY, Jove R, Haura EB. Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res 2006; 66: 5542-5548. (Pubitemid 43927102)
37. Allen MD, Vaziri R, Green M, Chelala C, Brentnall AR, Dreger S et al. Clinical and functional significance of alpha9beta1 integrin expression in breast cancer: A novel cell-surface marker of the basal phenotype that promotes tumour cell invasion. J Pathol 2011; 223: 646-658.
38. Hibi K, Yamakawa K, Ueda R, Horio Y, Murata Y, Tamari M et al. Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer. Oncogene 1994; 9: 611-619. (Pubitemid 24041541)